BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present new findings from patient-focused ...

Markets have reached all-time highs after equities staged a huge rally in Q2 after a rough start in April. However, investors ...

After months of AI-driven mania and MAG7 obsession, investors seem to be taking a breather, and VOO is reaping the rewards.

TURKU, FI / ACCESS Newswire / July 9, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - The oral presentation and poster showcase bexmarilimab's dual attack on cancer with new mechanistic data from ...